Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 2, 1998, Pages 184-189

  Wenning, G K ^a   Litvan, I ^b,h   Jankovic, J ^c   Granata, R ^a   Mangone, C A ^b   McKee, A ^d   Poewe, W ^a   Jellinger, K ^e   Chaudhuri, K Ray ^f   D'Olhaberriague, L ^b   Pearce, R K B ^g  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Institute of Neurology   (United Kingdom)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atypical parkinsonism; Clinicopathological study; Corticobasal degeneration; Natural history; Survival

Indexed keywords

LEVODOPA;

ADULT; AGED; APRAXIA; ARTICLE; AUSTRIA; AUTOPSY; BRADYKINESIA; BRAIN DEGENERATION; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; DISEASE COURSE; DISEASE DURATION; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HUMAN; MALE; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SURVIVAL TIME; TREMOR; UNITED KINGDOM; UNITED STATES;

EID: 0031947984     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.2.184     Document Type: Article

References (25)

1. Rinne JO, Lee MS, Thompson PD, et al. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117:1183-96.
2. Wenning GK, Pramstaller PP, Ransmayr G, et al. Atypische Parkinson-Syndrome. Nervenarzt 1997;68:102-15.
3. Watts RL, Mirra SS, Richardson EP. Corticobasal ganglionic degeneration. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994;282-99.
4. Litvan I, Agid Y, Goetz C, et al. Accuracy of clinical diagnosis of corticobasal degeneration. Neurology 1997;48:119-25.
5. Schneider JA, Watts RL, Gearing M, et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-89.
6. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-9.
7. Doodt RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry 1992;55:806-10.
8. Bergeron C, Pollanen MS, Weyer L, et al. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893-900.
9. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
10. Leiguarda RC, Pramstaller PP, Merello M, et al. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997;120:75-90.
11. Wenning GK, Ben Shlomo Y, Magalhaes N, et al. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-6.
12. Wenning GK, Ben Shlomo Y, Tison F, et al Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-47.
13. Ben-Shlomo Y, Wenning GK, Tison F, et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997;48:384-93.
14. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewksi syndrome) and clinical predictors of survival: a Clinicopathological study. J Neurol Neurosurg Psychiatry 1996;61:615-20.
15. Savoiardo M, Girotti F, Strada L, et al. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl 1994;42:93-110.
16. Grisoli M, Fetoni V, Savoiardo M, et al. MRI in corticobasal degeneration. Eur J Neurol 1995;2:547-52.
17. Sawle GV, Brooks DJ, Marsden CD, et al. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114: 541-56.
18. Eidelberg D, Dhawan V, Moeller JR, et al. The metabolic landscape of corticobasal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991;54:854-62.
19. Blin J, Vidaihlet MJ, Pillon B, et al. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992;7:348-54.
20. Brooks DJ. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 1993;43:S6-16.
21. Markus HS, Lees AJ, Lennox G, et al. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord 1995;10:179-87.
22. Frisoni BG, Pizzolato G, Biachetti A, et al. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT anaylsis. Eur Neurol 1995;35:50-4.
23. Vidailhet MJ, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994; 35:420-6.
24. Brunt ERP, van Weerden TW, Pruim J, et al. Unique myoclonic pattern in corticobasal degeneration. Mov Disord 1995;10:132-42.
25. Thompson PD, Day BL, Rothwell JC, et al. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994;117:1197-207.